Abiomed, Inc.

Symbol: ABMD

NASDAQ

381.02

USD

Market price today

  • 126.8485

    P/E Ratio

  • -5.7181

    PEG Ratio

  • 17.18B

    MRK Cap

  • 0.00%

    DIV Yield

Abiomed, Inc. (ABMD) Stock Split, History Data

Working capital analysis

In terms of working capital, Abiomed, Inc. maintains a healthy position. The total current assets of the company are valued at $976473000. This represents a growth rate of 23.923% compared to the previous year. Breaking down the current assets, the cash and investments are worth $132818000, exhibiting a growth rate of -42.926% year-on-year. The receivables, another significant portion of the current assets, are valued at $90608000. The year-on-year growth rate for receivables is -6.762%. The inventory, which forms a critical part of the assets, is valued at $93981000. This represents a healthy year-on-year growth of 15.941% On the liabilities side, the company's current liabilities total $138457000. This reflects a growth rate of 7.357% over the previous year, indicating the company's financial obligations are well under control.

202220212020201920182017
Cash and investments
132.82
232.71
192.34
121.02
42.98
39.04
Receavebles
90.61
97.18
84.65
90.81
70.01
54.05
Inventory
93.98
81.06
90.09
80.94
50.20
34.93
Other
33.28
26.03
18.01
13.75
11.81
8.02
Total Current Assets
976.47
787.97
635.86
677.20
494.27
326.96
Acc Payable
35.35
34.84
32.77
32.19
23.57
20.62
Short Term Debt
0.00
66.05
75.11
12.26
4.56
0.80
Other Current Liab
76.75
3.76
4.86
45.16
41.59
37.70
Current Liabilities
138.46
128.97
131.88
106.00
84.68
69.62

Capital Structure

When examining the capital structure of Abiomed, Inc., it is clear that the company manages a robust portfolio. The value of their total assets clocks in at $1696544000. When juxtaposed with the previous year, this marks a growth rate of 10.883%, showcasing the company's ability to steadily grow its asset base. Turning to liabilities, the company has total liabilities amounting to $156757000. Compared to the prior year, this reflects a growth rate of 7.758%. On the asset side, the cash and equivalent reserves are worth $182335000. The year-on-year growth of these reserves is -24.618%. The company's common stock, another important asset, holds a value of $452000, growing at a rate of -0.659% from the previous year. Finally, the company's retained earnings stand at $1125199000, marking a growth rate of 31.076% year-over-year. These earnings represent the profits that Abiomed, Inc. has chosen to reinvest in the business rather than distribute as dividends.

Total Assets

$1,696.54

Total liabilities

$156,757,000.00

Long term debt

$0.00

Cash and eqv

$182,335,000.00

Goodwill

$72.96

Retained earnings

$1,125,199,000.00

Common stock

$0.00

Enterprise Value

$43.20

Net earnings per share (EPS)

Abiomed, Inc. has an EPS of $4.87, which signifies the profit allocated per share of common stock. With a growth rate of 66.212% this year, it indicates the company's increasing profitability and potential for share value growth. This trend signals robust financial performance and future potential.

YearsQ1Q2Q3Q4Total
20221.22.34-1.334.87
2021-0.591.251.011.262.93
20200.991.381.370.714.45
20191.970.291.531.645.43
20182.021.1110.834.96
20170.850.560.30.342.05
20160.30.210.360.261.13
20150.210.180.252.43.04
2014-0.04270.090.310.090.45
2013-0.04450.030.110.10.20
20120.07970.140.06810.06560.36
2011-0.120.01570.0759-0.0463-0.07
2010-0.16-0.0862-0.02160.0263-0.24
2009-0.21-0.21-0.12-0.23-0.77
2008-0.28-0.18-0.21-0.46-1.13
2007-0.26-0.29-0.26-0.2-1.01
2006-0.23-0.33-0.25-0.14-0.95
2005-0.77-0.11-0.17-0.0092-1.06
2004-0.110.021-0.0092-0.0711-0.17
2003-0.15-0.13-0.0929-0.14-0.51
2002-0.26-0.25-0.21-0.0873-0.81
2001-0.3-0.34-0.31-0.2-1.15
2000-0.097-0.0721-0.18-0.15-0.50
1999-0.0861-0.35-0.21-0.16-0.81
1998-0.0632-0.29-0.27-0.31-0.93
19970.110.0567-0.140.0630.09
19960.05320.0353-0.05460.02350.06
19950.01210.00690.027-0.01440.04
1994-0.02-0.010-0.05-0.08
1993-0.06-0.03-0.03-0.06-0.18
1992-0.09-0.1-0.07-0.12-0.38
1991-0.08-0.1-0.10-0.28
199000000.00
198900000.00
198800000.00
198700000.00
1986000-0.00

Abiomed, Inc. (ABMD) stock split history

Understanding the historical stock splits of Abiomed, Inc. (ABMD) provides insights into its past financial decisions and investor sentiment. A stock split occurs when a company increases its share count by dividing its existing shares. The most recent split took place on October 02, 2000 with a ratio of 2:1. Throughout its history, the company has undergone 1 stock splits. Below, we delve deeper into this history, highlighting past financial strategies.

DateSplit Ratio
02 October 20002:1

Frequently Asked Question

What is the latest historical split date of the company?

The latest historical split date is N/A.

What is firm free cah flow per share (FCF per share)?

The free cah flow per share (FCF per share) is 5.493.

What is company revenue per share?

The company revenue per share is 0.361.

What are firm earnings per share?

The firm earnings per share is 0.716.

What is Abiomed, Inc. (ABMD) ROIC (return on capital)?

Abiomed, Inc. (ABMD) ROIC (return on capital) is 0.243.

What is dividend per share figure?

The dividend per share is 0.000

What is enterprise plowback ratio?

Abiomed, Inc. (ABMD) plowback ratio is N/A

What is firm enterprise value (EV)?

The enterprise value (EV) is 43.199

What is company debt to equity ratio?

The debt to equity ratio is 0.000

What are debt ratio numbers?

The debt ratio is 0.000

What is company price to sales ratio?

The price to sales ratio is 16.652